BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17487393)

  • 1. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
    Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
    Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells.
    Yoneda O; Imai T; Nishimura M; Miyaji M; Mimori T; Okazaki T; Domae N; Fujimoto H; Minami Y; Kono T; Bloom ET; Umehara H
    Eur J Immunol; 2003 Jan; 33(1):53-8. PubMed ID: 12594832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.
    Fraticelli P; Sironi M; Bianchi G; D'Ambrosio D; Albanesi C; Stoppacciaro A; Chieppa M; Allavena P; Ruco L; Girolomoni G; Sinigaglia F; Vecchi A; Mantovani A
    J Clin Invest; 2001 May; 107(9):1173-81. PubMed ID: 11342581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
    Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
    Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine in vascular biology: from basic research to clinical disease.
    Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
    Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
    Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
    Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
    Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
    Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel ULBP splice variants are ligands for human NKG2D.
    Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
    Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
    Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.
    Kikuchi T; Andarini S; Xin H; Gomi K; Tokue Y; Saijo Y; Honjo T; Watanabe A; Nukiwa T
    Infect Immun; 2005 Sep; 73(9):5350-7. PubMed ID: 16113250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
    Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells.
    Gehrmann M; Marienhagen J; Eichholtz-Wirth H; Fritz E; Ellwart J; Jäättelä M; Zilch T; Multhoff G
    Cell Death Differ; 2005 Jan; 12(1):38-51. PubMed ID: 15592361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
    Hosokawa Y; Nakanishi T; Yamaguchi D; Nakae H; Matsuo T
    Clin Exp Immunol; 2005 Mar; 139(3):506-12. PubMed ID: 15730397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.